Canadian Generics Maker's Warning

6 April 1997

Barry Sherman, chairman of Canadian generic maker Apotex Inc, haswritten to Liberal politicians in Ottawa, warning them that what he sees as their broken promises to Canadians over drug prices will come back to haunt them at the upcoming elections.

If the Liberal federal government does not keep the promises which its members made in opposition, to take steps to lower drug prices and limit patent protection for multinational drug firms, he writes: "I give you and your colleagues in Ontario caucus my personal undertaking to take this health debate to the Ontario public and we will place the facts in front of them. We will make them aware of how the Liberal party promised to lower drug prices in 1993 and then flipflopped in 1997 and broke its promise."

Mr Sherman urges the Liberals to "stand up in caucus and defend Ontario's interests, the interests of Canadian taxpayers, the health care system and the generic drug industry."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight